keyword
https://read.qxmd.com/read/38651684/trypanosomes-and-gut-microbiota-interactions-in-triatomine-bugs-and-tsetse-flies-a-vectorial-perspective
#1
REVIEW
Zeph Nelson Omondi, Ayşe Caner, Suha Kenan Arserim
Triatomines (kissing bugs) and tsetse flies (genus: Glossina) are natural vectors of Trypanosoma cruzi and Trypanosoma brucei, respectively. T. cruzi is the causative agent of Chagas disease, endemic in Latin America, while T. brucei causes African sleeping sickness disease in sub-Saharan Africa. Both triatomines and tsetse flies are host to a diverse community of gut microbiota that co-exist with the parasites in the gut. Evidence has shown that the gut microbiota of both vectors plays a key role in parasite development and transmission...
April 23, 2024: Medical and Veterinary Entomology
https://read.qxmd.com/read/38649106/morphometric-study-of-the-legs-of-the-main-chagas-vector-triatoma-infestans-hemiptera-reduviidae
#2
JOURNAL ARTICLE
Gastón Mougabure-Cueto, María Laura Hernández, Juan José Gilardoni, Julieta Nattero
In triatomines, vectors of Chagas disease, active dispersal takes place by walking and flying. Flight has received more attention than walking although the last is the dispersal modality used by nymphs due to their lack of wings and also used by adults, which would facilitate the colonization and reinfestation of houses after vector control actions. The present work studied the morphometrical variation of Triatoma infestans legs, the main vector of Chagas disease the Southern Cone of South America. We described morphometric traits and the natural variation of each leg segment...
April 20, 2024: Acta Tropica
https://read.qxmd.com/read/38648682/microalgae-extracts-modulates-the-immune-response-in-trypanosoma-cruzi-infected-human-cells
#3
JOURNAL ARTICLE
José Noé da Silva Júnior, Kamila Kassia Dos Santos Oliveira, Ana Carla da Silva, Virginia Maria Barros de Lorena, Daniela de Araújo Viana Marques, Raquel Pedrosa Bezerra, Ana Lúcia Figueiredo Porto
Chagas disease (CD) is caused by the hemoflagellate protozoan Trypanosoma cruzi. The control of the infection depends of the innate and acquired immune response of host. Moreover, CD plays a significant role in the immune response, and, in this context, microalgae can be an interesting alternative due to its immunomodulatory and trypanocidal effects. This study aimed to evaluate, in vitro, immunomodulatory potentials of the aqueous extracts of Chlorella vulgaris and Tetradesmus obliquus. Both microalgae extracts (ME) were obtained by sonication, and the selectivity index (SI) was determined by assays of inhibitory concentration (IC50 ) in T...
April 20, 2024: Cytokine
https://read.qxmd.com/read/38648355/fenofibrate-induces-a-resolving-profile-in-heart-macrophage-subsets-and-attenuates-acute-chagas-myocarditis
#4
JOURNAL ARTICLE
Javier Ruiz Luque, Ágata Carolina Cevey, Azul Victoria Pieralisi, Carolina Poncini, Fernando Erra Díaz, Marcus Vinicius Azevedo Reis, Martin Donato, Gerardo Ariel Mirkin, Nora Beatriz Goren, Federico Nicolás Penas
Chagas disease, caused by Trypanosoma cruzi , stands as the primary cause of dilated cardiomyopathy in the Americas. Macrophages play a crucial role in the heart's response to infection. Given their functional and phenotypic adaptability, manipulating specific macrophage subsets could be vital in aiding essential cardiovascular functions including tissue repair and defense against infection. PPARα are ligand-dependent transcription factors involved in lipid metabolism and inflammation regulation. However, the role of fenofibrate, a PPARα ligand, in the activation profile of cardiac macrophages as well as its effect on the early inflammatory and fibrotic response in the heart remains unexplored...
April 22, 2024: ACS Infectious Diseases
https://read.qxmd.com/read/38648351/comparative-analysis-of-health-related-fitness-in-patients-with-acute-versus-chronic-chagas-disease
#5
JOURNAL ARTICLE
Clara Narcisa Silva Almeida, Ariane Cardoso Vasconcelos, Caroline da Silva Sousa, Nivea Thayanne Melo Silva, Dilma do Socorro Moraes de Souza, Carlos Alberto Marques de Carvalho, Suellen Alessandra Soares de Moraes, Laura Maria Tomazi Neves
INTRODUCTION: Although Chagas disease causes high levels of morbidity, the muscle function and tolerance to physical activity in Chagas disease patients are still not completely understood. OBJECTIVE: To compare health-related fitness of patient groups with acute Chagas disease versus chronic Chagas disease. MATERIALS AND METHODS: We conducted a cross-sectional study involving 18 patients. The data were obtained from patient´s records, and functional capacity was measured with the sixminute walk test, the peripheral muscle strength with handgrip strength, and respiratory muscle strength using the maximum inspiratory pressure and the maximum expiratory pressure...
March 31, 2024: Biomédica: Revista del Instituto Nacional de Salud
https://read.qxmd.com/read/38648342/-seroprevalence-of-trypanosoma-cruzi-among-children-from-veracruz-mexico-epidemiological-baseline-for-a-control-model-based-on-chagas-disease-active-transmission
#6
JOURNAL ARTICLE
Ernesto Pérez-Sánchez, Raúl Montiel-Cruz, Eréndira Romero-Domínguez, Griselda Pascacio-Bermúdez, Arturo Báez-Hernández, Guadalupe Díaz Del Castillo-Flores, Fabián Correa-Morales, Gonzalo Vázquez-Prokopec, Pablo Manrique-Saide, Azael Che-Mendoza, Gabriela Meneses-Ruiz, Irma López-Martínez, María Jesús Sánchez
Introduction. In 2021, the Secretaría de Salud de México and the Pan American Health Organization launched an initiative to interrupt intra-domiciliary vector transmission of Trypanosoma cruzi based on the prevalence of Chagas disease in children. The Mexican State of Veracruz was leading this initiative. Objective. To estimate the seroprevalence of T. cruzi infection among children under 15 years of age from rural areas of Veracruz, México. Materials and methods. We identified eight localities of high priority from the Municipality of Tempoal, Veracruz, for baseline serology...
March 31, 2024: Biomédica: Revista del Instituto Nacional de Salud
https://read.qxmd.com/read/38644164/in-vitro-and-in-vivo-study-of-a-photostable-quinone-compound-with-enhanced-therapeutic-efficacy-against-chagas-disease
#7
JOURNAL ARTICLE
Yutaka Suto, Nagisa Inoue, Mohammed Suliman Omer Tagod, Yoko Onizuka, Tomoya Nobuta, Mayumi Ishii, Daniel Ken Inaoka, Kayoko Kanamitsu, Noriyuki Yamagiwa, Junko Nakajima-Shimada
Chagas disease, a neglected tropical disease caused by the protozoan Trypanosoma cruzi poses a significant health challenge in rural areas of Latin America. The current pharmacological options exhibit notable side effects, demand prolonged administration, and display limited efficacy. Consequently, there is an urgent need to develop drugs that are safe and clinically effective. Previously, we identified a quinone compound (designated as compound 2) with potent antiprotozoal activity, based on the chemical structure of komaroviquinone, a natural product renowned for its antitrypanosomal effects...
2024: Chemical & Pharmaceutical Bulletin
https://read.qxmd.com/read/38643671/privileged-small-molecules-against-neglected-tropical-diseases-a-perspective-from-structure-activity-relationships
#8
REVIEW
J Abbasi Shiran, B Kaboudin, N Panahi, N Razzaghi-Asl
Neglected tropical diseases (NTDs) comprise diverse infections with more incidence in tropical/sub-tropical areas. In spite of preventive and therapeutic achievements, NTDs are yet serious threats to the public health. Epidemiological reports of world health organization (WHO) indicate that more than 1.5 billion people are afflicted with at least one NTD type. Among NTDs, leishmaniasis, chagas disease (CD) and human African trypanosomiasis (HAT) result in substantial morbidity and death, particularly within impoverished countries...
April 16, 2024: European Journal of Medicinal Chemistry
https://read.qxmd.com/read/38642092/multiparametric-magnetic-resonance-imaging-of-the-liver-and-spleen-in-gaucher-disease
#9
JOURNAL ARTICLE
Daniella Braz Parente, Fernanda Chagas Monteiro de Melo Malta, Renata de Souza Cravo, Ronir Raggio Luiz, Vivian Rotman, Renata Mello Perez, Rosana Souza Rodrigues
PURPOSE: To assess liver and spleen characteristics of a population with Gaucher disease (GD) using multiparametric MRI and MR elastography (MRE) for evaluation of diffuse liver and spleen disease, which includes liver fat fraction, liver and spleen volume and iron deposition, and liver and spleen stiffness correlated with DS3 Severity Scoring System for Gaucher disease (GD-DS3). METHODS: We prospectively evaluated 41 patients with type 1 Gaucher disease using a 3...
April 20, 2024: Abdominal Radiology
https://read.qxmd.com/read/38641825/characterization-of-the-patterns-of-care-access-and-direct-cost-of-systemic-lupus-erythematosus-in-brazil-findings-from-the-macuna%C3%A3-ma-study
#10
REVIEW
Mirhelen Mendes de Abreu, Odirlei Andre Monticielo, Vander Fernandes, Dalianna Luise Andrade Souto Rodrigues, Cristhiane Almeida Leite da Silva, Alexandre Cristovão Maiorano, Fernando Dos Santos Beserra, Flavia Rachel Moreira Lamarão, Bruna Medeiros Gonçalves de Veras, Nathalie David, Magda Araújo, Marcelly Cristinny Ribeiro Alves, Matheus Amaral Stocco, Fernando Mello Lima, Emilly Borret, Andrese Aline Gasparin, Gustavo Flores Chapacais, Guilherme Andrade Bulbol, Diogo da Silva Lima, Natália Jardim Martins da Silva, Marta Maria Costa Freitas, Blanca Elena Rios Gomes Bica, Domingos Sávio Nunes de Lima, Marta Maria das Chagas Medeiros
BACKGROUND: A cost of illness (COI) study aims to evaluate the socioeconomic burden that an illness imposes on society as a whole. This study aimed to describe the resources used, patterns of care, direct cost, and loss of productivity due to systemic lupus erythematosus (SLE) in Brazil. METHODS: This 12-month, cross-sectional, COI study of patients with SLE (ACR 1997 Classification Criteria) collected data using patient interviews (questionnaires) and medical records, covering: SLE profile, resources used, morbidities, quality of life (12-Item Short Form Survey, SF-12), and loss of productivity...
April 19, 2024: Advances in Rheumatology
https://read.qxmd.com/read/38635818/validation-of-trypanosoma-cruzi-inactivation-techniques-for-laboratory-use
#11
JOURNAL ARTICLE
Lorna M MacLean, Mark Ariyanayagam, Lalitha Sastry, Christy Paterson, Manu De Rycker, Alan H Fairlamb
Trypanosoma cruzi (T. cruzi) is the causative agent of Chagas' disease, a parasitic infection responsible for significant morbidity and mortality in Latin America. The current treatments have many serious drawbacks and new drugs are urgently required. In the UK, T. cruzi is classified by the Advisory Committee on Dangerous Pathogens (ACDP) as a Hazard Group 3 organism and strict safety practices must be adhered to when handling this pathogen in the laboratory. Validated inactivation techniques are required for safe T...
2024: PloS One
https://read.qxmd.com/read/38633251/omega-3-and-omega-6-polyunsaturated-fatty-acids-and-their-potential-therapeutic-role-in-protozoan-infections
#12
REVIEW
Sajid Ur Rahman, Tzu-Nin Weng, Abdul Qadeer, Saqib Nawaz, Hanif Ullah, Chien-Chin Chen
Protozoa exert a serious global threat of growing concern to human, and animal, and there is a need for the advancement of novel therapeutic strategies to effectively treat or mitigate the impact of associated diseases. Omega polyunsaturated fatty acids (ω-PUFAs), including Omega-3 (ω-3) and omega-6 (ω-6), are constituents derived from various natural sources, have gained significant attention for their therapeutic role in parasitic infections and a variety of essential structural and regulatory functions in animals and humans...
2024: Frontiers in Immunology
https://read.qxmd.com/read/38631020/anti-trypanosomal-lignans-isolated-from-salvadoran-peperomia-pseudopereskiifolia
#13
JOURNAL ARTICLE
Ulises G Castillo, Yoshinori Uekusa, Takehiro Nishimura, Fumiyuki Kiuchi, Morena L Martínez, Jenny Menjívar, Junko Nakajima-Shimada, Marvin J Núñez, Haruhisa Kikuchi
A search for anti-trypanosomal natural compounds from plants collected in El Salvador, a country particularly endemic for Chagas disease, resulted in the isolation of five lignan-type compounds ( 1 - 5 ) from Peperomia pseudopereskiifolia . The lignan derivatives 1 , 2 , and 4 are new. Their absolute configuration was determined by chemical derivatization. Compounds 1 , 5 , 6 , and 8 exhibited anti-trypanosomal activity against the amastigote form of T. cruzi comparable to that of the existing drug benznidazole...
April 17, 2024: Journal of Natural Products
https://read.qxmd.com/read/38629580/extracellular-vesicles-translational-agenda-questions-for%C3%A2-three-protozoan-parasites
#14
JOURNAL ARTICLE
Kwesi Z Tandoh, Ana Victoria Ibarra-Meneses, David Langlais, Martin Olivier, Ana Claudia Torrecilhas, Christopher Fernandez-Prada, Neta Regev-Rudzki, Nancy O Duah-Quashie
The protozoan parasites Plasmodium falciparum, Leishmania spp. and Trypanosoma cruzi continue to exert a significant toll on the disease landscape of the human population in sub-Saharan Africa and Latin America. Control measures have helped reduce the burden of their respective diseases-malaria, leishmaniasis and Chagas disease-in endemic regions. However, the need for new drugs, innovative vaccination strategies and molecular markers of disease severity and outcomes has emerged because of developing antimicrobial drug resistance, comparatively inadequate or absent vaccines, and a lack of trustworthy markers of morbid outcomes...
April 2024: Traffic
https://read.qxmd.com/read/38627301/new-2-nitroimidazole-n-acylhydrazones-analogs-of-benznidazole-as-anti-trypanosoma-cruzi-agents
#15
JOURNAL ARTICLE
Marcelly C S R Pitombeira, Policarpo A S Júnior, Silvane Maria Fonseca Murta, Alvaro Romanha, Pedro H Luccas, M Cristina Nonato, Rafael E O Rocha, Rafaela S Ferreira, Flávia F da Silveira, Frederico S Castelo-Branco, Alcione S Carvalho, Nubia Boechat
Chagas disease is a neglected tropical parasitic disease caused by the protozoan Trypanosoma cruzi. Worldwide, an estimated 8 million people are infected with T. cruzi, causing more than 10,000 deaths per year. Currently, only two drugs, nifurtimox and benznidazole (BNZ), are approved for its treatment. However, both are ineffective during the chronic phase, show toxicity, and produce serious side effects. This work aimed to obtain and evaluate novel 2-nitroimidazole-N-acylhydrazone derivatives analogous to BNZ...
April 16, 2024: Archiv der Pharmazie
https://read.qxmd.com/read/38626209/machine-learning-for-predicting-chagas-disease-infection-in-rural-areas-of-brazil
#16
JOURNAL ARTICLE
Fabio De Rose Ghilardi, Gabriel Silva, Thallyta Maria Vieira, Ariela Mota, Ana Luiza Bierrenbach, Renata Fiuza Damasceno, Lea Campos de Oliveira, Alexandre Dias Porto Chiavegatto Filho, Ester Sabino
INTRODUCTION: Chagas disease is a severe parasitic illness that is prevalent in Latin America and often goes unaddressed. Early detection and treatment are critical in preventing the progression of the illness and its associated life-threatening complications. In recent years, machine learning algorithms have emerged as powerful tools for disease prediction and diagnosis. METHODS: In this study, we developed machine learning algorithms to predict the risk of Chagas disease based on five general factors: age, gender, history of living in a mud or wooden house, history of being bitten by a triatomine bug, and family history of Chagas disease...
April 16, 2024: PLoS Neglected Tropical Diseases
https://read.qxmd.com/read/38623843/molecular-regulation-of-nlrp3-inflammasome-activation-during-parasitic-infection
#17
JOURNAL ARTICLE
Rasha Alonaizan
Parasitic diseases are a serious global health concern, causing many common and severe infections, including Chagas disease, leishmaniasis,and schistosomiasis. The NLRP3 inflammasome belongs to the NLR (nucleotide-binding domain leucine-rich-repeat-containing proteins) family, which are cytosolic proteins playing key roles in the detection of pathogens. NLRP3 inflammasomes are activated in immune responses to Plasmodium,Leishmania, Toxoplasma gondii, Entamoeba histolytica,Trypanosoma cruzi and other parasites...
April 16, 2024: Bioscience Reports
https://read.qxmd.com/read/38617820/chagas-heart-disease-is-associated-with-decreased-physical-activity-levels-a-cross-sectional-analysis
#18
JOURNAL ARTICLE
Leonardo Gonçalves Ribeiro, Tatiana Rehder Gonçalves, Vitor Barreto Paravidino, Henrique Silveira Costa, Luiz Fernando Rodrigues Junior, Flavia Mazzoli-Rocha, Gilberto Marcelo Sperandio da Silva, Fernanda de Souza Nogueira Sardinha Mendes, Roberto Magalhães Saraiva, Alejandro Marcel Hasslocher-Moreno, Mauro Felippe Felix Mediano
BACKGROUND: Studies evaluating physical activity (PA) levels in individuals with Chagas disease (CD) are still scarce. The present study aimed to evaluate PA levels in CD individuals and examine their association with Chagas heart disease (ChHD). METHODS: We included patients with CD regularly followed in a reference center for treatment of infectious diseases. PA levels were assessed using the short version of the International Physical Activity Questionnaire (IPAQ)...
June 2024: IJC Heart & Vasculature
https://read.qxmd.com/read/38617611/metallomics-an-essential-tool-for-the-study-of-potential-antiparasitic-metallodrugs
#19
REVIEW
Ignacio Machado, Dinorah Gambino
Metallomics is an emerging area of omics approaches that has grown enormously in the past few years. It integrates research related to metals in biological systems, in symbiosis with genomics and proteomics. These omics approaches can provide in-depth insights into the mechanisms of action of potential metallodrugs, including their physiological metabolism and their molecular targets. Herein, we review the most significant advances concerning cellular uptake and subcellular distribution assays of different potential metallodrugs with activity against Trypanosma cruzi , the protozoan parasite that causes Chagas disease, a pressing health problem in high-poverty areas of Latin America...
April 9, 2024: ACS Omega
https://read.qxmd.com/read/38612650/chagas-disease-a-silent-threat-for-dogs-and-humans
#20
REVIEW
João Durães-Oliveira, Joana Palma-Marques, Cláudia Moreno, Armanda Rodrigues, Marta Monteiro, Graça Alexandre-Pires, Isabel Pereira da Fonseca, Gabriela Santos-Gomes
Chagas disease (CD) is a vector-borne Neglected Zoonotic Disease (NZD) caused by a flagellate protozoan, Trypanosoma cruzi , that affects various mammalian species across America, including humans and domestic animals. However, due to an increase in population movements and new routes of transmission, T. cruzi infection is presently considered a worldwide health concern, no longer restricted to endemic countries. Dogs play a major role in the domestic cycle by acting very efficiently as reservoirs and allowing the perpetuation of parasite transmission in endemic areas...
March 29, 2024: International Journal of Molecular Sciences
keyword
keyword
73921
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.